BioSpace News Archive

Tarveda Therapeutics, Inc., a clinical stage biopharmaceutical company developing a new class of potent and selective precision oncology medicines, which it refers to as Pentarin® miniature drug conjugates, today announced the appointment of Brian Roberts as President and Chief Executive Officer effective September 30, 2020.

The Oregon Bioscience Association invites high school through post-doctoral researchers as well as bio entrepreneurs leading early- and later-stage startups from Oregon and Southwest Washington to compete in Oregon Bio’s expanded pitch events.

Sarepta Therapeutics, Inc., the leader in precision genetic medicine for rare diseases, granted equity awards on September 30, 2020 that were previously approved by the Compensation Committee of its Board of Directors under Sarepta’s 2014 Employment Commencement Incentive Plan, as a material inducement to employment to 37 individuals hired by Sarepta in September 2020.

GI Windows Medical Corp, a clinical-stage, privately-held medical device company pioneering new advancements in anastomosis technology announced the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for the self-forming magnetic compression anastomosis device indicated for small bowel end to end anastomosis for ileostomy reversal or tissue resection.